Category Archives for "News"

Abattis Provides Corporate Updates

Abattis Provides Corporate Updates July 11, 2018    |    Abattis Bioceuticals Abattis Bioceuticals Corp. (the “Company” or “Abattis”) (CSE:ATT) (OTC:ATTBF) is pleased to provide the following corporate updates. Completion of Private Placement Abattis has completed a non-brokered private placement for gross proceeds of $2.25 million (the “Proceeds”) through the issuance of 13,235,294 common shares […]

Read More

ABATTIS ENTERS INTO DEFINITIVE AGREEMENT TO LAUNCH NEW CANNABIS LAB IN ONTARIO

ABATTIS ENTERS INTO DEFINITIVE AGREEMENT TO LAUNCH NEW CANNABIS LAB IN ONTARIO June 28, 2018    |    Abattis Bioceuticals Abattis Bioceuticals Corp. (the “Company” or “Abattis”) (CSE:ATT) (OTC:ATTBF) is pleased to announce that it has entered into a definitive investment agreement dated June 27, 2018 (the “Agreement”) with XLABS Therapeutics (ONT) Inc. (“XLABS”) to […]

Read More

ABATTIS AND BLOCKSTRAIN EXECUTE LETTER OF INTENT FOR PRODUCT INTEGRATION AND STRATEGIC PARTNERSHIP

ABATTIS AND BLOCKSTRAIN EXECUTE LETTER OF INTENT FOR PRODUCT INTEGRATION AND STRATEGIC PARTNERSHIP June 05, 2018    |    Abattis Bioceuticals Abattis Bioceuticals Corp. (the “Company” or “Abattis”) (CSE:ATT) (OTC:ATTBF) and BLOCKSTRAIN TECHNOLOGY CORP. (“BLOCKStrain”) (TSXV: DNAX.V) are pleased to announce that they have signed a letter of intent (the “LOI”) to integrate BLOCKStrain’s proprietary technology […]

Read More

Abattis and Vergence Naturals Launch New Marketing Campaign

Abattis and Vergence Naturals Launch New Marketing Campaign May 24, 2018    |    Abattis Bioceuticals Abattis Bioceuticals Corp. (the “Company” or “Abattis”) (CSE:ATT) (OTC:ATTBF) and its wholly-owned subsidiary, Vergence Naturals Ltd. (“Vergence”), have launched their “Live. Love. Life. Naturally!” marketing campaign to build awareness for their naturally inspired health and beauty brands for the conventional […]

Read More

Abattis Bioceuticals Announces Release of New Line of Vaporizers

Abattis Bioceuticals Announces Release of New Line of Vaporizers May 22, 2018    |    Abattis Bioceuticals Abattis Bioceuticals Corp. (the “Company” or “Abattis”) (CSE:ATT) (OTC:ATTBF) is pleased to announce the addition of three new vaporizers to its product line. Since the Company’s acquisition of Green Tree Therapeutics (“Green Tree”) earlier this year, Abattis has been […]

Read More

Abattis Signs Agreement with Cannamedix to Support the Development and Commercialization of CBD-infused Natural Health Products

Abattis Signs Agreement with Cannamedix to Support the Development and Commercialization of CBD-infused Natural Health Products May 17, 2018    |    Abattis Bioceuticals Abattis Bioceuticals Corp. (the “Company” or “Abattis”) (CSE:ATT) (OTC:ATTBF) is pleased to announce it has entered into a non-binding letter of intent (the “LOI“) with Cannamedix Inc. (“Cannamedix”) to provide Cannamedix with, […]

Read More
1 2 3 7